Anti-VEGF treatment strategies for wet AMD

Research output: Contribution to journalReview articlepeer-review

92 Scopus citations

Abstract

Over the past few years, antivascular endothelial growth factor (VEGF) therapy has become a standard treatment for neovascular age-related macular degeneration (AMD). During this time, treatment strategies have evolved from a monthly dosing schedule to individualized regimens. This paper will review the currently available anti-VEGF agents and evidence-based treatment strategies.

Original languageEnglish (US)
Article number786870
JournalJournal of Ophthalmology
Volume2012
DOIs
StatePublished - 2012

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Anti-VEGF treatment strategies for wet AMD'. Together they form a unique fingerprint.

Cite this